Acute Onset Human Atrial Fibrillation Is Associated With Local Cardiac Platelet Activation and Endothelial Dysfunction

Journal of the American College of Cardiology

Volumn 51, Issue 18, 2008, Pages 1790-1793

  Akar, Joseph G ^a   Jeske, Walter ^a   Wilber, David J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; ENOXAPARIN; INTERLEUKIN 6; NITRIC OXIDE; PADGEM PROTEIN; WARFARIN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SINUS RHYTHM; THROMBOCYTE ACTIVATION;

ACUTE DISEASE; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CATHETER ABLATION; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PLATELET ACTIVATION; PROTHROMBIN; RISK FACTORS; THROMBIN; THROMBOPHILIA;

EID: 42949158660     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.083     Document Type: Article

References (11)

1. Yip H.K., Chang L.T., Sun C.K., et al. Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J 47 (2006) 371-379
2. Conway D.S., Pearce L.A., Chin B.S., Hart R.G., and Lip G.Y. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 106 (2002) 1962-1967
3. Goette A., Ittenson A., Hoffmanns P., et al. Increased expression of P-selectin in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1872-1875
4. Minamino T., Kitakaze M., Sanada S., et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 98 (1998) 1721-1727
5. Li-Saw-Hee F.L., Blann A.D., Gurney D., and Lip G.Y. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 22 (2001) 1741-1747
6. Choudhury A., Chung I., Blann A.D., and Lip G.Y. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. J Am Coll Cardiol 49 (2007) 1957-1964
7. Miles A.M., Wink D.A., Cook J.C., and Grisham M.B. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol 268 (1996) 105-120
8. Atalar E., Haznedaroglu I.C., Acil T., et al. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets 14 (2003) 407-411
9. Sohara H., Amitani S., Kurose M., and Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 29 (1997) 106-112
10. Li-Saw-Hee F.L., Blann A.D., Goldsmith I., and Lip G.Y. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. Am J Cardiol 83 (1999) 1206-1209
11. Cai H., Li Z., Goette A., et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106 (2002) 2854-2858